N/A
N=25
Investigation of a Supporting Ostomy Product Intended for Leakage Detection
Stoma Ileostomy
Bottom Line
View on ClinicalTrials.gov: NCT04894084 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: System Performance Accuracy of Pictures — 122; 126; 24; 45 Pictures
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- CP321 (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Coloplast A/S
- Primary completion
- Jul 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY System Performance Accuracy of Pictures |
122; 126; 24; 45 | — |
| SECONDARY Frequency of Leakage Onto Clothes Before and After Use of Test Product |
2.84; 0.51 | <0.001 sig |
| SECONDARY Experience of Leakage Onto Clothes Compared to Only Using Usual Product |
0; 0; 2; 3; 18 | <0.0001 sig |
| SECONDARY Reliability of Notifications |
5; 7; 6; 3; 2 | 0.0106 sig |
| SECONDARY Ability to Move With Test Product |
0; 1; 16; 4; 2 | <0.0001 sig |
| SECONDARY Subjects Worry of Leakage Before and After Use of Test Product |
1; 11; 11; 2; 0; 0 | <0.001 sig |
| SECONDARY Confidence to Avoid Full Leakage With Test Product Compared to Only Using Usual Product |
18; 5 | 0.0106 sig |
| SECONDARY Confidence in Daily Life Compared to Only Using Usual Product |
1; 2; 5; 10; 5 | 0.21 |
| SECONDARY Feeling of Control With Test Product Compared to Only Using Usual Product |
18; 5 | 0.0106 sig |
| SECONDARY Control of Leakage Progression With Test Product Compared to Only Using Usual Product |
16; 7 | 0.093 |
| SECONDARY Feeling of Security With Test Product Compared to Only Using Usual Product |
1; 22 | <0.0001 sig |
| SECONDARY Evaluation of Confidence to Increase Social Activities With Test Product Compared to Only Using Usual Product |
2; 21 | <0.0001 sig |
| SECONDARY Evaluation of Sleep With Test Product Compared to Only Using Usual Product |
8; 0; 15 | 0.21 |
| SECONDARY Confidence at Night With Test Product Compared to Only Using Usual Product |
0; 1; 11; 7; 4 | 1.00 |
| SECONDARY Evaluation of Users' Preference |
10; 13 | 0.678 |
| SECONDARY Reason for Preference |
2; 1; 10; 2; 9; 2 | — |
| SECONDARY Evaluation of Users' Peace of Mind With Test Product |
6; 10; 5; 2 | 0.0931 |
| SECONDARY To Evaluate Users' Assessment of QoL With Test Product Compared to Usual Product |
3; 20 | 0.0005 sig |
| SECONDARY Adhesive Residue to Skin |
6; 7; 7; 2; 1 | — |
| SECONDARY Adhesive Residue to Transmitter |
9; 5; 9; 0; 0 | — |
Summary
People with intestinal stomas (especially an ileostomy) can have, despite development of better ostomy products, problems with leakage which influence their quality of life negatively.
To overcome this, Coloplast has developed a new supporting ostomy product, which has an adhesive sensor layer that should be place underneath the baseplate normally used by the subject.
Single arm design. Open-labelled Study duration: 21 days + 3 days.
Eligibility Criteria
Inclusion Criteria
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Have had a stoma for more than three months
- Have intact skin on the area used in the evaluation meaning no broken skin and only minor discoloration of the skin (assessed by investigator)
- Be able to use one of the five sensor layer sizes (i.e. Ø40, Ø50, Ø60, Ø70, Ø80 mm)
- Ileo- or colostomists with liquid output (Bristol scale type 6-7).
- Currently using a Coloplast product (1pc/2pc Flat/Convex/Concave) from e.g Assura/SenSura/SenSura Mio
- Have self-reported problems with leakage* (three times within 14 days)
- Have worry of leakage 'to some, high or very high degree'
- Is familiar with the use of a smartphone *Leakage: Leakage is defined as output from the stoma on the backside of the baseplate (underneath the baseplate)
Exclusion Criteria
- Currently receiving or have within the past 2 month received radio- and/or chemotherapy
- Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
- Are pregnant or breastfeeding
- Participating in other interventional clinical investigations or have previously participated in this investigation. Exception: Participation in other Coloplast sponsored clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this protocol.
- Known sensitivity towards test product
- Known sensitivity towards acrylate
- Is using/have a pacemaker
- Is using ostomy paste or ostomy powder
Data sourced from ClinicalTrials.gov (NCT04894084). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.